Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers—for the External Quality Assurance in Thrombosis and Haemostasis Group

Abstract

External quality assessment (EQA) is used to evaluate laboratory performance in tests of hemostasis; however, some esoteric tests are performed by too few centers in any one EQA program to allow valid statistical assessment. To explore the feasibility of pooling data from several EQA providers, an exercise was carried out by the External Quality Assurance in Thrombosis and Haemostasis group, using the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee (SSC) plasma standard for thrombophilia screening assays. Six EQA providers took part in this exercise, distributing the SSC plasma standard as a “blinded” sample to participants for thrombophilia tests between November 2020 and December 2021. Data were collected by each provider, anonymized, and pooled for analysis. Results were analyzed as overall results from each EQA provider, and by kit/method-specific comparisons of data from all providers pooled together. For each parameter, median results and range were determined. Over 1,250 sets of data were returned in the six EQA programs. The overall medians (all data pooled) were <4% of the assigned values for each parameter with the exception of protein C activity by clot-based assay. Method-related differences in median results were observed for free protein S antigen and protein S activity—a pattern seen across data from the different EQA providers. Antithrombin antigen results reported in mg/dL provided an example where small numbers of results for a single EQA provider may be supplemented by pooling data from multiple providers with good agreement seen among results reported by the different EQA providers. This study demonstrated that a multicenter EQA provider collaboration can be carried out and demonstrated benefit for assays with smaller number of participants. In addition, results showed good agreement with the assigned values of the SSC plasma standard. Further exercises for tests performed by only small numbers of laboratories can be planned.

Keywords

quality assurance - thrombophilia - proficiency testing

Publication History

Article published online:
16 August 2024

• References

• 1 Miller WG. The role of proficiency testing in achieving standardization and harmonization between laboratories. Clin Biochem 2009; 42 (4–5): 232-235
• 2 Olson JD, Jennings I, Meijer P. et al. Lack of grading agreement among international hemostasis external quality assessment programs. Blood Coagul Fibrinolysis 2018; 29 (01) 111-119
• 3 Marlar RA, Meijer P, Jennings I, Olson J. on behalf of EQATH. (External Quality Assurance in Thrombosis and Hemostasis). Guidance document for development of an external quality assurance program in hemostasis and thrombosis. Consistent accuracy: a goal for thrombosis and hemostasis testing is accomplished using an external quality assurance program. Ann Blood 2020; 5: 9
• 4 SSC Secondary plasma standard lot #5. Accessed January 11, 2024 at: https://nibsc.org/products/brm_product_catalogue/detail_page.aspx?catid=SSCLOT5
• 5 Jennings I, Reilly-Stitt C, Lowe A, Kitchen S, Walker I. The United Kingdom National External Quality Assessment Scheme (UK NEQAS) Experience. External quality assessment data for investigation of von Willebrand disease: focus on relative utility of contemporary functional von Willebrand factor assays. Semin Thromb Hemost 2022; 48 (06) 732-738
• 6 SSC/ISTH secondary coagulation standard calibration report for lot #5. Accessed January 16, 2024 at: https://cdn.ymaws.com/www.isth.org/resource/resmgr/subcommittees/ssc_lot_5_calibration_report.pdf
• 7 Jennings I, Kitchen S, Woods TAL, Preston FE. Laboratory performance of haemophilia centres in developing countries: 3 years' experience of the World Federation of Hemophilia External Quality Assessment Scheme. Haemophilia 1998; 4 (05) 739-746
• 8 Jennings I, Kitchen DP, Woods TA, Kitchen S, Walker ID, Preston FE. Laboratory performance in the World Federation of Hemophilia EQA programme, 2003-2008. Haemophilia 2009; 15 (02) 571-577
• 9 Cunningham MT, Brandt JT, Chandler WL. et al. Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program. Semin Thromb Hemost 2007; 33 (03) 250-258
• 10 Smock KJ, Moser KA. What have we learned from coagulation laboratory participation in external quality programs?. Int J Lab Hematol 2019; 41 (Suppl. 01) 49-55
• 11 Montalvão SAL, Lowe A, Kitchen S. Advantages of external quality assessment-EQA programs. Haemophilia 2022; 28 (04) 679-686
• 12 Favaloro EJ, Bonar R, Kershaw G. et al. Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance program. Semin Thromb Hemost 2006; 32 (05) 505-513
• 13 Verbruggen B, Dardikh M, Polenewen R, van Duren C, Meijer P. The factor VIII inhibitor assays can be standardized: results of a workshop. J Thromb Haemost 2011; 9 (10) 2003-2008
• 14 Haliassos A. Inter-laboratory comparisons and EQA in the Mediterranean area. EJIFCC 2018; 29 (04) 253-258
• 15 Jennings I, Perry D, Watson H. et al; Haemostasis and Thrombosis Task Force of the British Society for Haematology & UK NEQAS for Blood Coagulation. Quality assurance and tests of platelet function. Br J Haematol 2018; 181 (04) 560-561
• 16 Nederlof A, Kitchen S, Meijer P. et al. Performance of factor IX extended half-life product measurements in external quality control assessment programs. J Thromb Haemost 2020; 18 (08) 1874-1883
• 17 Favaloro EJ, Bonar R, Hollestelle MJ. et al. Differential sensitivity of von Willebrand factor activity assays to reduced VWF molecular weight forms: a large international cross-laboratory study. Thromb Res 2018; 166: 96-105
• 18 Salazar E, Long TA, Smock KJ. et al. Analysis of College of American Pathologists von Willebrand factor proficiency testing program. Semin Thromb Hemost 2022; 48 (06) 690-699
• 19 Badrick T, Miller WG, Panteghini M. et al. Interpreting EQA-understanding why commutability of materials matters. Clin Chem 2022; 68 (04) 494-500
• 20 Jennings I, Kitchen D, Kitchen S, Woods T, Walker I. The importance of commutability in material used for quality control purposes. Int J Lab Hematol 2019; 41 (01) 39-45
• 21 Wilmot HV, Rakowski K, Gray E. The traceability of commercial plasma calibrators to the plasma International Standards for factor VIII and factor IX. Int J Lab Hematol 2020; 42 (06) 810-818